Guideline Recommendations and Comparing CAR T-Cell Therapy With Transplant

The moderator reviews a guideline recommendation on CAR T-cell therapy and T-cell engagers at first relapse, and one panelist describes how it compares with their practice, including the rationale for sequencing and the questions that remain open. Panelists then compare transplant eligibility with CAR T-cell eligibility, including age, fitness, and caregiver requirements, and share how patients describe their experience of CAR T-cell therapy compared with transplant.